Clinical Trial Update: Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating eluxadoline for irritable bowel syndrome with diarrhea in pediatric patients. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Viberzi (eluxadoline)

Snippet

Sponsor: AbbVie | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: RECRUITING